US 9492523
Broadly protective Shigella vaccine based on type III secretion apparatus proteins
granted A61KA61K2039/54A61K2039/543
Quick answer
US patent 9492523 (Broadly protective Shigella vaccine based on type III secretion apparatus proteins) held by The Board of Regents for Oklahoma State University expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents for Oklahoma State University
- Grant date
- Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2039/54, A61K2039/543, A61K2039/55544, A61K2039/58